| Notice Filed with SOS |
03/30/2012 |
| Rule |
ProposedRuleAttach2012-00294.DOC |
| Statutory Authority |
10-1-109, 10-3-1104.5(3)(d)(II) and 10-3-1110 |
| Description of Subjects/Issues |
4-2-9 CONCERNING NON-DISCRIMINATORY TREATMENT OF ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) RELATED ILLNESS BY LIFE AND HEALTH CARRIERS |
| Purpose/Objective of Rule |
The purpose of this regulation is to establish standards that will assure non¬discriminatory treatment with respect to AIDS and HIV infection in underwriting practices, policy forms and benefit provisions utilized by entities subject to the provisions of this regulation. It also establishes what HIV/AIDS medical tests, permitted under § 10-3-1104.5, C.R.S., are considered medically reliable for underwriting decisions. |
| Comments |
Mike Conway |
| Submitted in response to issues raised by COLS/OLLS? |
No
|
| Is this rule adopted in response to recent legislation? |
|
| Hearing Date |
05/01/2012 |
| Hearing Time |
10:00 AM |
| Hearing Location |
1560 Broadway Ste 850 Denver CO 80202 |
| Contact Name |
Christine Gonzales-Ferrer |
| Contact Title |
Rulemaking Coordinator |
| Contact Telephone |
303-894-2157 |
| Contact email |
christine.gonzales-ferrer@dora.state.co.us |